These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 447112)

  • 41. Part II. The systemic treatment of gallstones.
    Tompkins RK
    Adv Surg; 1976; 10():87-98. PubMed ID: 824939
    [No Abstract]   [Full Text] [Related]  

  • 42. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
    Wang HH; Portincasa P; Wang DQ
    Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cholelithiasis. Physiopathologic mechanisms].
    Rautureau J
    Nouv Presse Med; 1972 Jun; 1(23):1553-5. PubMed ID: 5035883
    [No Abstract]   [Full Text] [Related]  

  • 44. The physicochemical basis of cholesterol gallstone formation in man.
    Admirand WH; Small DM
    J Clin Invest; 1968 May; 47(5):1043-52. PubMed ID: 5645851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
    Nakano K; Chijiiwa K
    Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of lincomycin as a cholesterol gallstone dissolution rate accelerator.
    Rush BD; Ruwart MJ; Anderson BD; Higuchi WI
    J Pharm Sci; 1985 Jun; 74(6):621-4. PubMed ID: 4020649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ursodeoxycholic acid versus chenodeoxycholic acid. Comparison of their effects on bile acid and bile lipid composition in patients with cholesterol gallstones.
    Stiehl A; Czygan P; Kommerell B; Weis HJ; Holtermüller KH
    Gastroenterology; 1978 Dec; 75(6):1016-20. PubMed ID: 30674
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of ioglycamide (Biligram) on bile flow and biliary lipid secretion in man.
    Bell GD; Doran J; Fayadh M; Murphy G; Dowling RH
    Gut; 1978 Apr; 19(4):300-7. PubMed ID: 648936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenesis of human cholesterol cholelithiasis.
    Strasberg SM; Fisher MM
    Can Med Assoc J; 1975 Feb; 112(4):484-8. PubMed ID: 1089468
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones.
    Coyne MJ; Bonorris GG; Goldstein LI; Schoenfield LJ
    J Lab Clin Med; 1976 Feb; 87(2):281-91. PubMed ID: 1245792
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of tegaserod on bile composition and hepatic secretion in Richardson ground squirrels on an enriched cholesterol diet.
    Mathison R; Shaffer E; Pfannkuche HJ; Earnest D
    Lipids Health Dis; 2006 Jun; 5():15. PubMed ID: 16792807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Effect of Chinese herbal preparation on major constituents of bile of gallstones patients].
    An X; Shi MY; Guo ZW
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Sep; 14(9):525-7. PubMed ID: 7865998
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Cholesterol gallstone pathogenesis].
    Méndez N; Uribe M; Jessurun J; Uscanga L
    Rev Invest Clin; 1990 Jul; 42 Suppl():53-7. PubMed ID: 19256135
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The cholesterol saturation of bile and its reduction by chenodeoxycholic acid in massively obese patients.
    Whiting MJ; Hall JC; Iannos J; Roberts HG; Watts JM
    Int J Obes; 1984; 8(6):681-8. PubMed ID: 6533091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of a pharmacological dose of cholecystokinin on bile acid kinetics and biliary cholesterol saturation in man.
    Jazrawi RP; Northfield TC
    Gut; 1986 Apr; 27(4):355-62. PubMed ID: 3957106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of interruption of enterohepatic circulation on biliary lipid secretion in man.
    Mok HY; von Bergmann K; Grundy SM
    Am J Dig Dis; 1978 Dec; 23(12):1067-75. PubMed ID: 736014
    [No Abstract]   [Full Text] [Related]  

  • 60. [Cholesterol crystals, cholesterol saturation of bile and biliary lithiasis].
    Poupon R; Chrétien Y; Darnis F
    Gastroenterol Clin Biol; 1984 Mar; 8(3):260-3. PubMed ID: 6714561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.